DCHA as Postremission Therapy for AML With t(8;21)

NCT03453255 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Chinese PLA General Hospital